Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of MLH1 mRNA | affects expression | 21346803
|
C027576 |
4-hydroxy-2-nonenal |
4-hydroxy-2-nonenal results in decreased expression of MLH1 mRNA | decreases expression | 12419474
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of MLH1 mRNA | affects expression | 17562736
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of MLH1 mRNA | decreases expression | 12419474
|
D003520 |
Cyclophosphamide |
Cyclophosphamide results in decreased expression of MLH1 mRNA | decreases expression | 11906922
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of MLH1 mRNA | increases expression | 20106945
|
C014347 |
decitabine |
decitabine affects the methylation of MLH1 promoter | affects methylation | 18069755
|
C014347 |
decitabine |
[decitabine co-treated with trichostatin A] affects the methylation of MLH1 promoter | affects cotreatment|affects methylation | 18069755
|
C014347 |
decitabine |
decitabine results in decreased methylation of MLH1 promoter | decreases methylation | 19080631 19032668
|
C014347 |
decitabine |
decitabine results in increased expression of MLH1 | increases expression | 19080631
|
C014347 |
decitabine |
decitabine results in increased expression of MLH1 mRNA | increases expression | 19417133 19032668
|
C014347 |
decitabine |
decitabine results in increased expression of MLH1 protein | increases expression | 19259094
|
C014347 |
decitabine |
PXD101 promotes the reaction [decitabine results in increased expression of MLH1 protein] | increases expression|increases reaction | 19259094
|
D004052 |
Diethylnitrosamine |
[Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of MLH1 mRNA | affects cotreatment|decreases expression | 18253720
|
D004052 |
Diethylnitrosamine |
[Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of MLH1 mRNA | affects cotreatment|increases expression | 18775883
|
D004054 |
Diethylstilbestrol |
Diethylstilbestrol results in increased expression of MLH1 mRNA | increases expression | 15766595
|
D004054 |
Diethylstilbestrol |
MLH1 gene mutant form affects the susceptibility to Diethylstilbestrol | affects response to substance | 15700306
|
C045651 |
epigallocatechin gallate |
epigallocatechin gallate results in decreased methylation of MLH1 promoter | decreases methylation | 14633667
|
C045651 |
epigallocatechin gallate |
epigallocatechin gallate results in increased expression of MLH1 mRNA | increases expression | 14633667
|
C045651 |
epigallocatechin gallate |
epigallocatechin gallate results in increased expression of MLH1 protein | increases expression | 14633667
|
D011345 |
Fenofibrate |
[Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of MLH1 mRNA | affects cotreatment|decreases expression | 18253720
|
D011345 |
Fenofibrate |
[Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of MLH1 mRNA | affects cotreatment|increases expression | 18775883
|
D011345 |
Fenofibrate |
Fenofibrate results in increased expression of MLH1 mRNA | increases expression | 18775883
|
D005472 |
Fluorouracil |
MLH1 mRNA affects the susceptibility to Fluorouracil | affects response to substance | 18497967
|
D005472 |
Fluorouracil |
MLH1 protein affects the susceptibility to Fluorouracil | affects response to substance | 18949393
|
D005472 |
Fluorouracil |
MLH1 protein results in increased susceptibility to Fluorouracil | increases response to substance | 17914563
|
C419708 |
gefitinib |
gefitinib results in decreased expression of MLH1 mRNA | decreases expression | 16685379
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide results in increased expression of MLH1 mRNA | increases expression | 15458575
|
C051890 |
irinotecan |
MLH1 protein affects the susceptibility to irinotecan | affects response to substance | 18949393
|
C015329 |
lycopene |
lycopene results in increased expression of MLH1 mRNA | increases expression | 16886892
|
D008769 |
Methylnitronitrosoguanidine |
Methylnitronitrosoguanidine results in decreased expression of MLH1 protein | decreases expression | 17671175
|
D008770 |
Methylnitrosourea |
Methylnitrosourea promotes the reaction [MSH2 protein binds to MLH1 protein binds to PMS2 protein] | affects binding|increases reaction | 16204460
|
D008770 |
Methylnitrosourea |
MLH1 affects the reaction [MGMT protein affects the reaction [Methylnitrosourea results in increased activity of CASP3 protein]] | affects reaction|increases activity | 13679151
|
D008770 |
Methylnitrosourea |
MLH1 protein affects the susceptibility to Methylnitrosourea | affects response to substance | 12967659
|
D008770 |
Methylnitrosourea |
MLH1 protein promotes the reaction [MGMT protein results in decreased susceptibility to Methylnitrosourea] | decreases response to substance|increases reaction | 13679151
|
D010269 |
Paraquat |
Paraquat results in increased expression of MLH1 mRNA | increases expression | 15458575
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of MLH1 mRNA | increases expression | 20127075
|
C487081 |
PXD101 |
PXD101 promotes the reaction [decitabine results in increased expression of MLH1 protein] | increases expression|increases reaction | 19259094
|
C037219 |
quinoline |
quinoline analog results in increased expression of MLH1 mRNA | increases expression | 19417133
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of MLH1 mRNA | increases expression | 12634122
|
C047246 |
temozolomide |
MLH1 protein affects the susceptibility to temozolomide | affects response to substance | 12967659
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of MLH1 mRNA | increases expression | 19465110
|
C012589 |
trichostatin A |
[decitabine co-treated with trichostatin A] affects the methylation of MLH1 promoter | affects cotreatment|affects methylation | 18069755
|
D014415 |
Tunicamycin |
Tunicamycin results in increased expression of MLH1 mRNA | increases expression | 15458575
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.62 | 14514962 11752688 15322242 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.91 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
4.62 | 17638652 |
MESH:D000230 |
Adenocarcinoma |
|
Methylnitrosourea |
4.62 | 15688392 15113128 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
2.72 | 6695378 10737359 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
15.95 | 16434500 19061943 19052882 17620307 18056438 17162532 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
15.95 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
15.95 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.47 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.67 | 17306315 16712894 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Paraquat |
3.54 | 11874814 |
MESH:D000686 |
Amyloidosis |
|
Diethylstilbestrol |
4.26 | 15469931 |
MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
4-hydroxy-2-nonenal |
3.96 | 10965797 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
8.02 | 17963324 15504547 16511603 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
8.02 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.61 | 10982225 |
MESH:D001161 |
Arteriosclerosis |
|
Cyclophosphamide |
4.37 | 15014928 |
MESH:D001249 |
Asthma |
|
epigallocatechin gallate |
3.32 | 16516891 |
MESH:D001254 |
Astrocytoma |
|
temozolomide |
6.25 | 15865885 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.44 | 18445737 |
MESH:D001327 |
Autoimmune Diseases |
|
epigallocatechin gallate |
4.84 | 19761891 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
8.09 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.09 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.56 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.62 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Cyclophosphamide |
3.62 | 12006526 18234424 16978400 17388661 18323546 11325840 15136595 17020986 15093573 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
3.62 | 18320071 19208741 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
3.62 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylstilbestrol |
3.62 | 17129689 15324884 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
3.62 | 15136595 18608205 19217205 16110121 18357371 16595493 16557594 |
MESH:D001943 |
Breast Neoplasms |
|
Methylnitrosourea |
3.62 | 14633655 11306469 16253758 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
3.62 | 20435547 |
MESH:C537421 |
Cafe au lait spots, multiple |
marker/mechanism |
|
| |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
4.44 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
7.59 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
7.59 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
16.26 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
16.26 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cyclophosphamide |
16.26 | 19701751 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
16.26 | 17978847 20524982 17138121 10672840 18506893 16698587 18393292 18665156 19171122 18971187 18210153 20432363 21159647 11831363 16935385 16540662 16779866 20101231 19701751 17428255 20007298 19107877 19539802 20935162 16328049 18056438 19919837 18494052 16569478 17055752 16878318 16807293 20214788 20512989 16502159 17162532 20727157 10737359 19052882 16681979 3084413 19519916 17173139 19418558 18788625 16830150 19208518 19394651 16288022 18691550 17761372 18785209 20514400 20084675 19822196 19383236 19335982 18978308 3581430 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylstilbestrol |
16.26 | 16924424 15948411 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
16.26 | 16332177 16799960 17045692 18930000 17088986 17971768 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
quinoline |
16.26 | 598648 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
16.26 | 15276417 16507464 17306315 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Cyclophosphamide |
4.66 | 16152834 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
gefitinib |
3.87 | 19233551 18347146 17290066 15496427 16230376 20005069 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Cyclophosphamide |
6.46 | 16201981 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
6.46 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
7.21 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
7.21 | 18986760 16757204 16280240 17066447 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
7.21 | 18572023 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.24 | 18670907 18850075 16120746 |
MESH:D002318 |
Cardiovascular Diseases |
|
Hydrogen Peroxide |
3.36 | 16936243 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
7.11 | 10977129 |
MESH:D002386 |
Cataract |
|
Methylnitrosourea |
7.11 | 12484553 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
24.35 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
24.35 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
24.35 | 17174075 2727394 21159647 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylnitronitrosoguanidine |
24.35 | 2727394 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylnitrosourea |
24.35 | 7505956 2727394 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
24.35 | 19524636 20056578 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
8.69 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
8.69 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.20 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.20 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.01 | 12621046 8697196 15668235 15340226 16354765 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
5.66 | 17616700 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
5.66 | 15001691 17018589 16510598 17287894 17725105 17016597 17169374 16340194 18772588 17172411 |
MESH:D003110 |
Colonic Neoplasms |
|
irinotecan |
5.66 | 17725105 17287894 |
OMIM:609310 |
COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2 |
marker/mechanism |
|
| |
MESH:D015179 |
Colorectal Neoplasms |
marker/mechanism |
|
| 18497967 18718023 18949393 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
4.70 | 18981723 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
4.70 | 18802399 17016601 18383874 16391804 16524972 15289873 20501625 17094418 17401013 17594712 17454858 17255274 18509181 18288408 15148649 18949393 17695437 18448328 14970324 16331619 16282729 16303861 |
MESH:D015179 |
Colorectal Neoplasms |
|
gefitinib |
4.70 | 17594712 |
MESH:D015179 |
Colorectal Neoplasms |
|
irinotecan |
4.70 | 18259882 17454858 17159606 15273666 16391804 18509181 16303861 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.87 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.24 | 15322242 10048152 20055451 |
MESH:D003456 |
Cryptorchidism |
|
Diethylstilbestrol |
4.34 | 12952375 16002989 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
3.79 | 18551238 |
MESH:D003556 |
Cystitis |
|
Cyclophosphamide |
4.75 | 18483878 16614059 18295254 18093676 12161096 18433785 10700343 10498854 16651033 16413132 17010015 18372110 17979934 12388444 18710439 12913760 11948286 15276878 15643279 16989017 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.56 | 16733453 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.32 | 18249437 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Cyclophosphamide |
3.88 | 10990075 15331540 11751995 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Cyclophosphamide |
3.15 | 18772604 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
6.87 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
epigallocatechin gallate |
6.87 | 16988119 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
6.87 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
8.36 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
8.36 | 12540782 10915739 15619225 17906064 10774834 19085960 11739529 15968718 11743745 11421492 12153990 14725611 11529661 18713872 19164858 19416960 19370779 11461765 14986274 18071297 14550746 17522070 17562736 16781746 16393943 11287661 10663392 19739265 16485898 16177239 2444490 12705907 12392966 16081117 16227642 16109766 19923254 19420014 12958197 11834606 12594235 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
8.36 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
8.36 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.87 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.59 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Fenofibrate |
4.26 | 16707586 |
MESH:D004487 |
Edema |
|
pirinixic acid |
5.87 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
5.87 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.67 | 18230668 15322242 16714409 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
13.26 | 19294695 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
trichostatin A |
13.26 | 19294695 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Diethylstilbestrol |
4.46 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Diethylstilbestrol |
7.46 | 16804899 15700306 |
MESH:D016889 |
Endometrial Neoplasms |
|
Fenofibrate |
7.46 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.82 | 10568697 9294722 |
MESH:D004802 |
Eosinophilia |
|
Cyclophosphamide |
3.99 | 11006010 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.89 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
2.39 | 17638652 16337965 16785472 16481741 15173087 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.84 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
11.86 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
11.86 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
11.86 | 19236843 20131406 |
MESH:D052776 |
Female Urogenital Diseases |
|
Diethylstilbestrol |
3.52 | 16513791 16534752 16611131 16002989 15751030 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.23 | 11858732 |
MESH:D005354 |
Fibrosarcoma |
|
Methylnitrosourea |
5.00 | 11555667 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
7.74 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
7.74 | 20067830 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.44 | 16983495 |
MESH:D005833 |
Genital Neoplasms, Female |
|
Diethylstilbestrol |
12.05 | 16452187 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
12.05 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.99 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
temozolomide |
7.63 | 15865885 |
MESH:D005909 |
Glioblastoma |
|
trichostatin A |
7.63 | 18801729 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
9.72 | 16145905 |
MESH:D005910 |
Glioma |
|
Methylnitrosourea |
9.72 | 9825942 |
MESH:D005910 |
Glioma |
|
temozolomide |
9.72 | 10871815 16327979 |
MESH:D018316 |
Gliosarcoma |
|
Cyclophosphamide |
5.28 | 11389073 |
MESH:D005911 |
Gliosis |
|
Paraquat |
4.93 | 11124998 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.36 | 10696789 |
MESH:D006086 |
Graft vs Host Disease |
|
Cyclophosphamide |
4.81 | 15172196 11014644 16376943 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
7.40 | 19215824 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
7.40 | 15162350 15102660 18337622 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.21 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.40 | 20558911 |
MESH:D006390 |
Hemangioendothelioma |
|
quinoline |
5.67 | 598648 |
MESH:D006394 |
Hemangiosarcoma |
|
quinoline |
4.79 | 598648 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.19 | 15720958 |
MESH:D006467 |
Hemophilia A |
|
Cyclophosphamide |
5.06 | 11918545 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.13 | 11000095 |
MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Cyclophosphamide |
5.30 | 14986274 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
7.52 | 16221962 19176532 19772884 18467677 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
7.52 | 15340226 12621046 16120746 |
MESH:D006689 |
Hodgkin Disease |
|
Cyclophosphamide |
6.99 | 16135485 17606976 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
6.99 | 12676792 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.81 | 16959395 15340226 18606429 8697196 16354765 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.52 | 16870215 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.99 | 20558911 |
MESH:D006965 |
Hyperplasia |
|
Diethylstilbestrol |
4.21 | 14722030 12960047 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
4.66 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.66 | 18670907 18850075 |
MESH:D006976 |
Hypertension, Pulmonary |
|
gefitinib |
4.53 | 18424623 |
MESH:D017380 |
Hypertrophy, Right Ventricular |
|
gefitinib |
6.01 | 18424623 |
MESH:D007021 |
Hypospadias |
|
Diethylstilbestrol |
4.35 | 16002989 |
MESH:D007154 |
Immune System Diseases |
|
Cyclophosphamide |
5.10 | 16076520 |
MESH:D007246 |
Infertility |
|
Diethylstilbestrol |
4.14 | 15036965 |
MESH:D007248 |
Infertility, Male |
|
Cyclophosphamide |
19.55 | 7193160 16517039 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
19.55 | 17581917 |
MESH:D007248 |
Infertility, Male |
|
Methylnitrosourea |
19.55 | 7193160 |
MESH:D007248 |
Infertility, Male |
|
Paraquat |
19.55 | 4850670 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
19.55 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
4.51 | 18785209 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
4.51 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.49 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.13 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.21 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
9.25 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
9.25 | 18776723 10903974 8314463 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
9.25 | 20008137 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Hydrogen Peroxide |
4.07 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
21.41 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
21.41 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Diethylstilbestrol |
21.41 | 16762066 14681315 15003126 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
21.41 | 16985049 |
MESH:D007680 |
Kidney Neoplasms |
|
gefitinib |
21.41 | 18625569 |
MESH:D007859 |
Learning Disorders |
|
Diethylstilbestrol |
3.84 | 17184923 |
MESH:D007938 |
Leukemia |
|
Cyclophosphamide |
10.19 | 10602166 |
MESH:D007938 |
Leukemia |
|
decitabine |
10.19 | 19235587 18980019 |
MESH:D007938 |
Leukemia |
|
temozolomide |
10.19 | 17500047 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Cyclophosphamide |
3.40 | 17802794 17658394 18587576 18172266 17008537 17296974 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Cyclophosphamide |
3.92 | 10373061 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
3.80 | 19117987 18454857 17236224 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
4.13 | 19387464 19010910 18206229 18460780 18704418 17679729 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
trichostatin A |
4.13 | 18206229 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.23 | 18055864 |
MESH:D007970 |
Leukopenia |
|
Cyclophosphamide |
4.74 | 11830472 10052129 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Methylnitrosourea |
4.04 | 15526292 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.70 | 18407596 18522880 19638242 18665156 20032147 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
epigallocatechin gallate |
4.79 | 17481882 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Fenofibrate |
4.79 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
4.79 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
4.79 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
3.70 | 19784758 11587558 16610002 12969438 19460945 16611625 19014921 12587719 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
3.70 | 17034775 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.04 | 16871587 17185352 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
24.44 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
24.44 | 21047994 19294768 20118626 19499222 20583210 19690152 15885732 18754104 19996281 20101389 20501860 16942905 19833225 12771043 19551842 19073162 9163691 19426721 19850985 18644402 19090486 15175105 19256749 21278145 21167192 19638242 2422723 18648771 21071580 19254457 20492335 18977376 10737359 20452335 19642983 19812893 20405173 20137499 20434301 12112319 19255062 19427195 2862719 18978307 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylstilbestrol |
24.44 | 16712894 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Fenofibrate |
24.44 | 18978307 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
24.44 | 16603448 17045692 15113037 18383874 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
24.44 | 15890375 16377806 20007298 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
24.44 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
24.44 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
12.99 | 6135515 2876786 2876784 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
12.99 | 18544905 17854601 19009564 16842330 19539802 18282651 19126423 18253720 16267830 18093689 18079962 19519916 18775883 2563599 3124819 17174075 21159647 18164116 18308698 17942915 19004024 9362446 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Fenofibrate |
12.99 | 18253720 18775883 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
12.99 | 12151625 |
MESH:D038061 |
Lower Extremity Deformities, Congenital |
|
Methylnitrosourea |
5.24 | 16080182 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.02 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
6.29 | 20970405 20512841 6695378 21163286 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
6.29 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Methylnitrosourea |
6.29 | 18062963 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
6.29 | 16712894 17306315 17077188 19931552 15276417 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
6.29 | 19555203 11884234 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.56 | 15086387 |
MESH:D008181 |
Lupus Nephritis |
|
Diethylstilbestrol |
4.92 | 15166399 |
MESH:D008223 |
Lymphoma |
marker/mechanism |
|
| 15700306 |
MESH:D008223 |
Lymphoma |
|
Cyclophosphamide |
16.63 | 12854902 |
MESH:D008223 |
Lymphoma |
|
decitabine |
16.63 | 19470736 |
MESH:D008223 |
Lymphoma |
|
Diethylstilbestrol |
16.63 | 15700306 |
MESH:D008223 |
Lymphoma |
|
Methylnitrosourea |
16.63 | 16257854 11418001 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Cyclophosphamide |
9.94 | 16675587 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Methylnitrosourea |
9.94 | 14633661 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Cyclophosphamide |
3.98 | 11911406 |
MESH:D052801 |
Male Urogenital Diseases |
|
Diethylstilbestrol |
5.28 | 16002989 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
gefitinib |
6.42 | 18375820 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Methylnitrosourea |
6.42 | 19196723 16619500 12931682 10767621 16944150 11807958 16051031 15313902 16827153 11751437 14633655 15113128 14999141 10838139 17131329 17020996 15688392 |
MESH:D008545 |
Melanoma |
|
decitabine |
9.40 | 16505122 17785578 |
MESH:D008545 |
Melanoma |
|
epigallocatechin gallate |
9.40 | 17992120 11746506 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
9.40 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
temozolomide |
9.40 | 18281670 12374674 17576461 16432458 15577323 16260697 16260693 10623706 16248763 12829675 17623835 16225601 |
MESH:D008545 |
Melanoma |
|
trichostatin A |
9.40 | 16505122 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
10.08 | 19513568 |
MESH:D008546 |
Melanoma, Experimental |
|
Cyclophosphamide |
10.08 | 16388313 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.56 | 16801185 |
MESH:D053842 |
Microsatellite Instability |
|
Methylnitronitrosoguanidine |
5.66 | 17671175 |
OMIM:276300 |
MISMATCH REPAIR CANCER SYNDROME |
marker/mechanism |
|
| |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
3.46 | 18986760 16757204 |
MESH:D052016 |
Mucositis |
|
irinotecan |
4.78 | 17159606 |
MESH:D055653 |
Muir-Torre Syndrome |
marker/mechanism |
|
| |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
7.12 | 18172295 |
MESH:D009101 |
Multiple Myeloma |
|
trichostatin A |
7.12 | 18172295 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
epigallocatechin gallate |
5.26 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.28 | 16239165 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
3.25 | 19010910 16882708 19157545 18608210 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.05 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.84 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.77 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
3.63 | 7678174 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
marker/mechanism |
|
| 17717427 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
9.22 | 9029167 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
irinotecan |
9.22 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
quinoline |
9.22 | 598648 |
MESH:D009369 |
Neoplasms |
|
Cyclophosphamide |
26.48 | 18854779 |
MESH:D009369 |
Neoplasms |
|
decitabine |
26.48 | 19116145 17925555 19470736 |
MESH:D009369 |
Neoplasms |
|
Diethylstilbestrol |
26.48 | 15313581 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
26.48 | 18239605 18600527 16928823 |
MESH:D009369 |
Neoplasms |
|
lycopene |
26.48 | 17051425 |
MESH:D009369 |
Neoplasms |
|
Methylnitrosourea |
26.48 | 15533788 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
26.48 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
26.48 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
Methylnitrosourea |
8.65 | 12696579 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
8.65 | 20056578 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.21 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.09 | 19348381 18481113 |
MESH:D009410 |
Nerve Degeneration |
|
Paraquat |
3.54 | 16893418 |
MESH:D009421 |
Nervous System Malformations |
|
Diethylstilbestrol |
8.92 | 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
8.92 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
3.00 | 12854658 |
MESH:D009442 |
Neurilemmoma |
|
Methylnitrosourea |
5.26 | 11555667 |
MESH:D009447 |
Neuroblastoma |
|
Cyclophosphamide |
11.09 | 8761367 16115947 15176712 |
MESH:D009447 |
Neuroblastoma |
|
irinotecan |
11.09 | 8761367 |
MESH:D009447 |
Neuroblastoma |
|
temozolomide |
11.09 | 15176712 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
7.57 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
7.57 | 20387270 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cyclophosphamide |
10.77 | 8761367 12837982 |
MESH:D017599 |
Neuroectodermal Tumors |
|
irinotecan |
10.77 | 8761367 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.89 | 20387270 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.29 | 16436463 |
MESH:D009503 |
Neutropenia |
|
Cyclophosphamide |
4.11 | 8291058 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.76 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.23 | 16049721 |
MESH:D009845 |
Oligospermia |
|
Cyclophosphamide |
4.48 | 16517039 |
MESH:D010051 |
Ovarian Neoplasms |
marker/mechanism |
|
| 19032668 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
7.62 | 19259094 19331143 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
7.62 | 15276417 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
trichostatin A |
7.62 | 19331143 |
MESH:D010146 |
Pain |
|
Acetaminophen |
6.25 | 16870215 |
MESH:D010146 |
Pain |
|
Cyclophosphamide |
6.25 | 12161096 18093676 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cyclophosphamide |
19.44 | 11332152 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
19.44 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
19.44 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
19.44 | 16500647 16929163 19003803 15113037 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Methylnitrosourea |
19.44 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
trichostatin A |
19.44 | 19294695 |
MESH:D010212 |
Papilloma |
|
Hydrogen Peroxide |
3.86 | 12065085 |
MESH:D010300 |
Parkinson Disease |
|
Paraquat |
2.73 | 16140633 11445065 15824117 15451049 16510128 11124998 11181820 12911755 |
MESH:D010302 |
Parkinson Disease, Secondary |
|
Paraquat |
4.21 | 16190885 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.02 | 12520081 |
MESH:D010787 |
Photosensitivity Disorders |
|
4-hydroxy-2-nonenal |
5.27 | 11550810 |
MESH:D010900 |
Pituitary Diseases |
|
Diethylstilbestrol |
4.94 | 14722030 |
MESH:D010911 |
Pituitary Neoplasms |
|
Diethylstilbestrol |
4.45 | 15687265 16977796 |
MESH:D011014 |
Pneumonia |
|
Paraquat |
4.22 | 12504350 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.34 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
8.31 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
8.31 | 2563599 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cyclophosphamide |
3.68 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Diethylstilbestrol |
8.80 | 17184923 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
8.80 | 11222880 11118676 11896295 11399792 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
11.68 | 17616702 |
MESH:D055728 |
Primary Myelofibrosis |
|
trichostatin A |
11.68 | 17616702 |
MESH:D011471 |
Prostatic Neoplasms |
marker/mechanism |
|
| 15583422 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cyclophosphamide |
2.41 | 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Diethylstilbestrol |
2.41 | 15846301 17136230 15046698 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
2.41 | 19082440 18626508 |
MESH:D011471 |
Prostatic Neoplasms |
|
gefitinib |
2.41 | 17914592 16685379 15651060 |
MESH:D011471 |
Prostatic Neoplasms |
|
lycopene |
2.41 | 15084515 17337101 |
MESH:D011471 |
Prostatic Neoplasms |
|
Methylnitrosourea |
2.41 | 12376480 15682402 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.41 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
trichostatin A |
2.41 | 18798265 19789329 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.15 | 16882103 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cyclophosphamide |
9.03 | 16636934 |
MESH:D011658 |
Pulmonary Fibrosis |
|
gefitinib |
9.03 | 18424623 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Paraquat |
9.03 | 16324872 17997886 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.82 | 18286688 18722050 16160472 15538739 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.28 | 19058328 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Paraquat |
3.70 | 11700416 |
MESH:D012135 |
Respiratory Sounds |
|
Paraquat |
3.83 | 11874814 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.62 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
Methylnitrosourea |
8.74 | 18155124 18172121 |
MESH:D012162 |
Retinal Degeneration |
|
Paraquat |
8.74 | 16458197 |
MESH:D012175 |
Retinoblastoma |
|
Methylnitrosourea |
5.26 | 11555667 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
4.19 | 19155313 |
MESH:D012595 |
Scleroderma, Systemic |
|
Cyclophosphamide |
4.61 | 16636934 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.39 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Hydrogen Peroxide |
12.70 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
12.70 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
12.70 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
12.70 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Diethylstilbestrol |
4.48 | 16709447 16002989 |
OMIM:102530 |
SPERMATOGENIC FAILURE 6 |
|
Cyclophosphamide |
5.28 | 16517039 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.62 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
6.17 | 19037991 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
6.17 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
6.17 | 18567086 16424979 16951190 18396642 15786421 17522103 17172411 17498489 19084572 19015929 |
MESH:D013274 |
Stomach Neoplasms |
|
irinotecan |
6.17 | 15723263 |
MESH:D013274 |
Stomach Neoplasms |
|
Methylnitrosourea |
6.17 | 15930296 18593901 16257854 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Cyclophosphamide |
4.83 | 12837982 |
MESH:D013953 |
Thymus Neoplasms |
|
Methylnitrosourea |
5.00 | 11418001 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.67 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
15.82 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
15.82 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
gefitinib |
15.82 | 16940797 |
MESH:D013964 |
Thyroid Neoplasms |
|
Methylnitrosourea |
15.82 | 3078959 7505956 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
3.79 | 16280240 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
14.87 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cyclophosphamide |
14.87 | 14692829 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
14.87 | 19087683 17616700 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Diethylstilbestrol |
14.87 | 16712894 16452187 17306315 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
14.87 | 16712894 16452187 17306315 11723127 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.09 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.77 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Diethylstilbestrol |
14.76 | 16175088 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
14.76 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
14.76 | 11813266 |
MESH:D014591 |
Uterine Diseases |
|
Diethylstilbestrol |
4.94 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Diethylstilbestrol |
3.85 | 15809267 16690809 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
4.68 | 17785578 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.75 | 1336536 |
MESH:D014625 |
Vaginal Neoplasms |
|
Diethylstilbestrol |
10.84 | 16002989 16513791 |
MESH:D014625 |
Vaginal Neoplasms |
|
temozolomide |
10.84 | 15577323 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.20 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.36 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.02 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.21 | 17120751 |